348 related articles for article (PubMed ID: 31838579)
1. High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer.
Marx AH; Mickler C; Sauter G; Simon R; Terracciano LM; Izbicki JR; Clauditz TS
Int J Colorectal Dis; 2020 Feb; 35(2):259-268. PubMed ID: 31838579
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.
Lugli A; Vlajnic T; Giger O; Karamitopoulou E; Patsouris ES; Peros G; Terracciano LM; Zlobec I
Hum Pathol; 2011 Dec; 42(12):1833-40. PubMed ID: 21664647
[TBL] [Abstract][Full Text] [Related]
3. High intratumoral FOXP3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancer.
Hanke T; Melling N; Simon R; Sauter G; Bokemeyer C; Lebok P; Terracciano LM; Izbicki JR; Marx AH
Int J Clin Exp Pathol; 2015; 8(7):8227-35. PubMed ID: 26339391
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of vascular and lymphovascular invasion in early lung cancer.
Al-Alao BS; Gately K; Nicholson S; McGovern E; Young VK; O'Byrne KJ
Asian Cardiovasc Thorac Ann; 2014 Jan; 22(1):55-64. PubMed ID: 24585645
[TBL] [Abstract][Full Text] [Related]
5. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
[TBL] [Abstract][Full Text] [Related]
6. Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer.
Betge J; Kornprat P; Pollheimer MJ; Lindtner RA; Schlemmer A; Rehak P; Vieth M; Langner C
Ann Surg Oncol; 2012 Nov; 19(12):3706-12. PubMed ID: 22669453
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of lymphovascular invasion in sporadic colorectal cancer.
Lim SB; Yu CS; Jang SJ; Kim TW; Kim JH; Kim JC
Dis Colon Rectum; 2010 Apr; 53(4):377-84. PubMed ID: 20305435
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral budding: A novel prognostic biomarker for tumor recurrence and a potential predictor of nodal metastasis in uterine cervical cancer.
Chong GO; Jee-Young Park N; Han HS; Cho J; Kim MG; Choi Y; Yeo JY; Lee YH; Hong DG; Park JY
Eur J Surg Oncol; 2021 Dec; 47(12):3182-3187. PubMed ID: 34284905
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.
Lugli A; Kirsch R; Ajioka Y; Bosman F; Cathomas G; Dawson H; El Zimaity H; Fléjou JF; Hansen TP; Hartmann A; Kakar S; Langner C; Nagtegaal I; Puppa G; Riddell R; Ristimäki A; Sheahan K; Smyrk T; Sugihara K; Terris B; Ueno H; Vieth M; Zlobec I; Quirke P
Mod Pathol; 2017 Sep; 30(9):1299-1311. PubMed ID: 28548122
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of tumor budding in gallbladder cancer: application of the International Tumor Budding Consensus Conference scoring system.
Kim HN; Lee SY; Kim BH; Kim CY; Kim A; Kim H
Virchows Arch; 2021 Jun; 478(6):1071-1078. PubMed ID: 33398430
[TBL] [Abstract][Full Text] [Related]
11. Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma.
Okuyama T; Oya M; Ishikawa H
Dis Colon Rectum; 2002 May; 45(5):628-34. PubMed ID: 12004212
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of lymphovascular invasion in stage II colorectal cancer patients with an inadequate examination of lymph nodes.
Gao Z; Cao H; Xu X; Wang Q; Wu Y; Lu Q
World J Surg Oncol; 2021 Apr; 19(1):125. PubMed ID: 33866973
[TBL] [Abstract][Full Text] [Related]
13. Impact of peritumoral and intratumoral budding in esophageal adenocarcinomas.
Thies S; Guldener L; Slotta-Huspenina J; Zlobec I; Koelzer VH; Lugli A; Kröll D; Seiler CA; Feith M; Langer R
Hum Pathol; 2016 Jun; 52():1-8. PubMed ID: 26980046
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
15. Predictors for lymph node metastasis in T1 colorectal cancer.
Suh JH; Han KS; Kim BC; Hong CW; Sohn DK; Chang HJ; Kim MJ; Park SC; Park JW; Choi HS; Oh JH
Endoscopy; 2012 Jun; 44(6):590-5. PubMed ID: 22638780
[TBL] [Abstract][Full Text] [Related]
16. The presence of poorly differentiated clusters predicts survival in stage II colorectal cancer.
Ammendola S; Turri G; Marconi I; Burato G; Pecori S; Tomezzoli A; Conti C; Pedrazzani C; Barresi V
Virchows Arch; 2021 Feb; 478(2):241-248. PubMed ID: 32577812
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of perineural invasion in stages II and III colorectal cancer.
Zhou Y; Wang H; Gong H; Cao M; Zhang G; Wang Y
Pathol Res Pract; 2015 Nov; 211(11):839-44. PubMed ID: 26429129
[TBL] [Abstract][Full Text] [Related]
18. The Relationship Between Tumor Budding, Tumor Microenvironment, and Survival in Patients with Primary Operable Colorectal Cancer.
van Wyk HC; Roseweir A; Alexander P; Park JH; Horgan PG; McMillan DC; Edwards J
Ann Surg Oncol; 2019 Dec; 26(13):4397-4404. PubMed ID: 31605345
[TBL] [Abstract][Full Text] [Related]
19. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
20. Budding and tumor-infiltrating lymphocytes - combination of both parameters predicts survival in colorectal cancer and leads to new prognostic subgroups.
Lang-Schwarz C; Melcher B; Haumaier F; Lang-Schwarz K; Rupprecht T; Vieth M; Sterlacci W
Hum Pathol; 2018 Sep; 79():160-167. PubMed ID: 29787819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
